Treatment strategy for acute uncomplicated urinary tract infections in women
Urinary tract infections (UTIs) are among the most common infectious diseases. Uncomplicated UTI usually develops in people without obstructive uropathies and structural changes in the kidney and urinary tract in the absence of background diseases. Unreasonable and irrational antibacterial therapy is a factor leading to the chronization of the process. The emergence of resistance of microbial strains to the most commonly used antibiotics causes a range of drugs to treat acute cystitis to be changed. Adequate antibiotic therapy is the cornerstone of successful treatment for acute uncomplicated cystitis. The once-daily antibiotic regimen has many undeniable advantages. Phosphomycin trometamol is a highly effective agent for the elimination of the causative agents of UTI and has a high safety profile.Pronkin E.A.
Keywords
uncomplicated urinary tract infections
uncomplicated cystitis
asymptomatic bacteriuria
cystitis in pregnant women
phosphomycin trometamol
References
1. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. М.; 2017. [Antimicrobial therapy and prevention of infections of the kidneys, urinary tract and male genital organs. Federal clinical guidelines. Moscow; 2017. (in Russian)]
2. Naber K.G., Schito G., Botto H., Palou J., Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur. Urol. 2008; 54(5): 1164-75.
3. European Association of Urology. EAU Guidelines urological infections; update 2017; 3.4.1. Available at: www.uroweb.org
4. Lutay N., Ambite I., Grönberg Hernandez J., Rydström G., Ragnarsdóttir B., Puthia M. et al. Bacterial control of host geneexpression through RNA polymerase II. J. Clin. Invest. 2013; 123(6): 2366-79.
5. Cai T., Mazzoli S., Mondaini N., Meacci F., Nesi G., D'Elia C. et al. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: To treat or not to treat? Clin. Infect. Dis. 2012; 55(6): 771-7.
6. Аляев Ю.Г., Глыбочко П.В., Пушкарь Д.Ю., ред. Урология. Клинические рекомендации. М.: ГЭОТАР-Медиа; 2016. 480с. [Alyaev Yu.G., Glybochko P.V., Pushkar D.Yu., ed. Urology. Clinical recommendations. Moscow: GEOTAR-Media; 2016. 480p. (in Russian)]
7. Köves B., Cai T., Veeratterapillay R., Pickard R., Seisen T., Lam T.B. et al. Benefits and harms of treatment of asymptomatic bacteriuria: a systematic review and meta-analysis by the European Association of Urology Urological Infection Guidelines Panel. Eur. Urol. 2017; 72(6): 865-8.
8. Зайцев А.В., Тупикина Н.В. Рецидивирующая инфекция мочевых путей - междисциплинарная проблема. Медицинский совет. 2014; 19: 36-44. [Zaitsev A.V., Tupikina N.V. Recurrent urinary tract infection is an interdisciplinary problem. Meditsinskiy sovet. 2014; 19: 36-44. (in Russian)]
9. Ho P.L., Wong R.C., Yip K.S., Loke S.L., Leung M.S., Mak G.C. et al. Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes. Diagn. Microbiol. Infect. Dis. 2007; 59(4): 439-45.
10. Gagliotti C., Buttazzi R., Sforza S., Moro M.L.; Emilia-Romagna Antibiotic Resistance Study Group. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli. J. Infect. 2008; 57(3): 179-84.
11. Falagas M.E., Vouloumanou E.K., Togias A.G., Karadima M., Kapaskelis A.M., Rafailidis P.I., Athanasiou S. Фосфомицин в сравнении с другими антибиотиками, применяемыми в лечении цистита – мета анализ рандомизированных контролируемых исследований. Экспериментальная и клиническая урология. 2013; 1: 94-102. [Falagas M.E., Vouloumanou E.K., Togias A.G., Karadima M., Kapaskelis A.M., Rafailidis P.I., Athanasiou S. Phosphomycin in comparison with other antibiotics used in the treatment of cystitis-meta analysis of randomized controlled trials. Eksperimental'naya i klinicheskaya urologiya. 2013; 1: 94-102. (in Russian)]
12. Falagas M.E., Roussos N., Gkegkes I.D., Rafailidis P.I., Karageorgopoulos D.E. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Expert Opin. Investig. Drugs. 2009;18(7): 921-44.
13. Bishop M.C. Uncomplicated urinaru tract infection. EAU Updated Series. 2014; 2(3): 143-50.
14. Falagas M.E., Kastoris A.C., Karageorgopoulos D.E., Rafailidis P.I. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of Systematic review 1875 JAC by guest on October 6, 2012. Available at: http://jac.oxfordjournals.org/ Downloaded from microbiological, animal and clinical studies. Int. J. Antimicrob. Agents. 2009; 34(2): 111-20.
15. Wagenlehner F.M., Thomas P.M., Naber K.G. Fosfomycin trometamol (3.000 mg) in perioperative antibiotic prophylaxis of healthcare-associated infections after endourological interventions: a narrative review. Urol. Int. 2014; 92(2): 125-30.
16. Палагин И.С., Cухорукова М.В., Гринев А.В., Перепанова Т.С., Козлов Р.С. Современное состояние антибиотикорезистентности возбудителей внебольничных инфекций мочевых путей в России: результаты исследований. Клиническая микробиология и антимикробная химиотерапия. 2012; 14(4): 280-302. [Palagin I.S., Suhorukova M.V., Grinev A.V., Perepanova T.S., Kozlov R.S. The current state of antibiotic resistance of pathogens of community-acquired infections of the urinary tract in Russia: the results of research. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya. 2012; 14(4): 280-302. (in Russian)]
17. Falagas M.E., Vouloumanou E.K., Togias A.G., Karadima M., Kapaskelis A.M., Rafailidis P.I., Athanasiou S. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J. Antimicrob. Chemother. 2010; 65(9): 1862-77.
18. Nicolle L.E., Bradley S., Colgan R., Rice J.C., Schaeffer A., Hooton T.M. Infectious Diseases Society of America guidelines for the diagnosis and treatment bacteriuria in adults. Clin. Infect. Dis. 2015: 40(5): 643-54.
19. European Association of Urology. EAU Guidelines urological infections; update 2017; 3.4.5. Available at: www.uroweb.org
20. Алиджанов Ж.Ф. Существуют ли альтернативные методы антибактериальной терапии и профилактики неосложненных инфекций мочевыводящих путей? Урология. 2014; 6: 5-13. [Alidzhanov Zh.F. Are there alternative methods for antibiotic therapy and prevention of uncomplicated urinary tract infections? Urologiya. 2014; 6: 5-13. (in Russian)]
21. Зайцев А.В., Колонтарев К.Б. Роль фосфомицина в лечении инфекций мочевыводящих путей. Урология. 2017; 4: 91-6. [Zaitsev A.V., Kolontarev K.B. The role of phosphomycin in the treatment of urinary tract infections. Urologiya. 2017; 4: 91-6. (in Russian)]
Received 08.06.2018
Accepted 22.06.2018
About the Authors
Pronkin, Evgeniy A., Candidate of Medical Science, Head of the Department of Urology, Clinical Hospital No. 123 of FMBA Russia.143003, Russia, Moscow Region, Odintsovo, Krasnogorskoye Shosse, 15. Tel.: +79255079546. E-mail: dr.pronkin@gmail.com
For citations: Pronkin E.A. Treatment strategy for acute uncomplicated urinary tract infections in women. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2018; (9): 165-9. (in Russian)
https://dx.doi.org/10.18565/aig.2018.9.165-169
Similar Articles
